The heparan sulfate proteoglycan Glypican 4 (Gpc4) is strongly expressed in mouse embryonic stem (ES) cells where it controls the maintenance of self-renewal by modulating Wnt/␤-catenin signaling activities. Here we show that mouse ES cells carrying a hypomorphic Gpc4 allele, in a single-step neuronal differentiation protocol, show increased differentiation into dopaminergic neurons expressing tyrosine hydroxylase (TH) and nuclear receptor related-1 protein (Nurr1) 1. In contrast to wild-type cells, these differentiating Gpc4-mutant cells expressed high levels of DOPA decarboxylase and the dopamine transporter, two markers expressed by fully mature dopaminergic neurons. Intrastriatal transplantation of Gpc4 hypomorphic cells into a 6-OHDA rat model for Parkinson's disease improved motor behavior in the cylinder test and amphetamine-induced rotations at a higher level than transplanted wild-type cells. Importantly, Gpc4 hypomorphic cell grafts, in contrast to wild-type cells, did not generate teratomas in the host brains, leading to strongly enhanced animal survival. Therefore, control of Gpc4 activity level represents a new potential strategy to reduce ES cell tumorigenic features while at the same time increasing neuronal differentiation and integration.
Introduction
Parkinson's disease (PD) is one of the most common neurodegenerative diseases. It is characterized by a progressive loss of midbrain dopamine (DA) neurons with a subsequent reduction in striatal DA (Olanow, 1999) . Pharmacological treatment with L-DOPA temporarily ameliorates clinical symptoms but induces severe complications, such as dyskinesias (Pearce et al., 2001) . Deep brain stimulation, although representing an efficient alternative treatment, can also have side effects (Olanow et al., 2000) . Celltherapeutic approaches in diseased humans have so far been based on the transplantation of fetal DA neurons, and clinical studies indicate that transplantation of these cells can induce symptomatic relief (Freed et al., 2001; Mendez et al., 2005) . However, immunological, logistical, technical, and ethical difficulties have limited the development and application of this approach (Lindvall, 2012) .
Embryonic stem (ES) cells or induced pluripotent stem (iPS) cells, differentiated toward the midbrain dopaminergic fate in vitro, represent an alternative source for cell replacement therapy in PD (Björklund and Isacson, 2002; Kim et al., 2002; Perrier et al., 2004; Arenas, 2010) . However, in vitro dopaminergic differentiation has to be finely controlled, and current protocols involving morphogens and drugs are complex and costly (Kriks et al., 2011) . Moreover, the risk associated with uncontrolled tissue growth in the brain needs to be abolished (Björklund and Isacson, 2002; . Indeed, rodent studies have shown tumor formation after ES cell transplantation (Björklund and Isacson, 2002; that was insufficiently reduced by the available differentiation protocols or cell sorting (Hedlund et al., 2008) . Therefore, the use of ES cells and iPS cells for therapy in PD remains currently elusive.
The cell surface protein Glypican 4 (Gpc4), one of the most abundant heparan sulfate proteoglycans expressed by mouse ES cells, controls the maintenance of stem cell self-renewal (Fico et al., 2012) . Remarkably, downregulation of Gpc4 in ES cells suppressed teratoma formation after grafting into the flank of nude mice. Moreover, ES cells with reduced expression levels for Gpc4 (Gpc4 gtϪ1 ) showed increased neuronal differentiation in vitro (Fico et al., 2012) .
Here we explore the ability of Gpc4 mutant cells to decrease teratoma formation and improve neuronal differentiation in a PD cell-based therapeutic context. We show that Gpc4 gtϪ1 ES cells generate increased amounts of mature DA neurons in vitro.
After transplantation of these cells in a rat PD model, dopaminergic differentiation in vivo was increased and accompanied by improved motor behavior. Moreover, Gpc4 gtϪ1 ES cells showed decreased teratoma formation, which correlated with enhanced animal survival.
Materials and Methods
In vitro experiments ES cell cultures and differentiation. ES cell lines PST132 and E14Tg2a were previously described (Niwa et al., 2000; Fico et al., 2012) . GFP was inserted in both ES cell lines at the Rosa26 locus by transfecting them with the R26P-SA-EGFPpuro plasmid (Addgene). Puromycin-selected ES cell clones were verified for correct self-renewal and differentiation properties and used as pools in all grafting experiments.
Cell lines were maintained on a monolayer of mitomycin-C-inactivated mouse fibroblasts in the presence of DMEM supplemented with 15% FBS, 100 M 2-mercaptoethanol, 1 ϫ MEM nonessential amino acids, 2 mM L-glutamine, 1 mM sodium pyruvate, and 100 units/ml LIF ESGRO (Millipore Bioscience Research Reagents).
Neuronal differentiation used a serum-free neural induction protocol (Fico et al., 2008) .
Immunofluorescence stainings and cell counts
Immunofluorescence stainings were done as described previously (Fico et al., 2012) . Primary antibodies used were mouse anti-NeuN (Millipore, 1:100), rabbit anti-GABA (Sigma, 1:300), and rabbit anti-tyrosine hydroxylase (TH, Millipore, 1:300). Quantitative immunocytochemical analysis was performed on randomly selected visual fields from two independent differentiation experiments. On average, 10 visual fields, at 20ϫ magnification were acquired and a total of 3000 NeuN ϩ cells were counted per experiment.
RNA preparation and RT-PCR
Total RNAs were isolated using RNeasy mini kit (QIAGEN) and reverse transcribed using QuantiTect Reverse Transcription kit (QIAGEN) following the manufacturer's instructions. qRT-PCR was performed using SYBR Green PCR master mix (EuroClone). Primers: TH, sense (s) tgtcacgtccccaaggttcat, antisense (as) gggcaggccgggtctctaagt; nuclear receptor related-1 protein (Nurr1), (s) gcccgatgtgggacgat, (as) tctgctcgatcatatgcgtagtg; DOPA decarboxylase (DDC), (s) gaacagacttaacgggagccttt, (as) aatgccggtagtcagtgataagc; dopamine transporter (DAT), (s) gtgggcttcactgtcatcctca, (as) cccaggtcatcaatgccacga; GAPDH, (s) atggggaaggtgaaggtcg, (as) gggtcattgatggcaacaatatc; no. of cycles was in all cases 30.
In vivo experiments lesions. Male Wistar rats were lesioned by intranigral 6-OHDA injection as described previously (Oueslati et al., 2007) . Lesioned animals were gtϪ1 ES cell grafts result in increased survival and behavioral improvements in parkinsonian rats. A, Timeline of the experimental approach. CT, Cylinder test; AIR, amphetamine-induced rotations test; wks, weeks. B, Graph reporting the cumulative death of rats after grafting. C, Data presented in the graph are the mean Ϯ SEM of the double contacts on the wall of the cylinder, expressed as the percentage of the total number of contacts. Note very consistent behavioral improvement in Gpc4 gtϪ1 after only 18 d after cell transplantation. Analyses were performed on n ϭ 7 animals at time 0 and 18 d, and on n ϭ 3 for wt graft and n ϭ 5 for Gpc4 gtϪ1 graft at 6 weeks. **p Ͻ 0.01 (Mann-Whitney test). ***p Ͻ 0.0001 (Mann-Whitney test). D, Amphetamine-induced rotational behavior in sham (no graft, white bar, n ϭ 8), wt graft (gray bar, n ϭ 4), and Gpc4 gtϪ1 graft animals (black bar, n ϭ 9). ***p Ͻ 0.0001 (Kruskal-Wallis test). ns, not significant. selected for transplantation based on their response to amphetamineinduced rotational behavior and asymmetry score in the cylinder test to get homogeneous groups of animals.
Immunosuppression
Cyclosporine A (10 mg/kg Sandimmun, Novartis) in sunflower seed oil (Sigma, S5007) was injected daily starting 1 d before surgery.
Transplantation procedures
For transplantations, ES cells were prepared as described by Björklund et al. (2002) . Briefly, the cells were seeded at 5 ϫ 10 6 cells in the absence of LIF. ES cells did not adhere to the dish but instead formed embryoid bodies. Four days later, embryoid bodies were dissociated with trypsin. 6-OHDA-lesioned animals received injections of 1 l of suspension (10,000 cells/l) into two sites of the right striatum (bregma: anterior 1.0 mm, lateral 3.0 mm, ventral 5.0 and 4.5 mm). Two independent cell transplantation experiments were performed.
Behavioral tests
Cylinder test was performed as reported previously to assess akinesia-like deficit of the forepaw contralateral to the lesion (Oueslati et al., 2007; Jouve et al., 2010 ). Lesioned rats were tested for rotational behavior in response to amphetamine (4 mg/kg i.p., Sigma). Behavior was monitored by a computerized activity monitor system and analyzed as described previously (Björklund and Isacson, 2002) .
Histological procedures, immunohistochemistry, and cell counting
Fifty-micrometer sections were prepared and labeled as described previously (de Chevigny et al., 2012) . Antibodies included the following: anti-TH (Aves, 1:1000; or Immunostar 1:1600), anti-GFP (Aves; 1:500), anti-nestin (Aves; 1:1000), anti-DAT (Santa Cruz Biotechnology; 1:100), anti-Pitx3 (gift from Austin Smith, 1:1000), anti-FoxA2 (Santa Cruz Biotechnology; 1:100), anti-calbindin (Millipore; 1:1000), anti-GABA (Sigma; 1:300), anti-serotonin (5-HT) (Immunostar; 1:500), and anti-dopamine D2 receptor (DRD2) (Millipore/Abcam; 1:150; specificity of the antibodies was validated on sections at the level of the substantia nigra). Images were acquired with Nikon macroconfocal or with Zeiss 510 Meta/780 confocal microscopes.
Measures of the three largest graft areas for each animal were performed from Nikon macroconfocal images (5ϫ lens, optical zoom ϫ3) using ImageJ. TH cell density was counted semiautomatically using ImageJ on every sixth section for each rat.
Evaluation of FoxA2, Pitx3, calbindin, and DAT expression in TH ϩ cells was done on 63ϫ Zeiss confocal microscope. Evaluation of GABA, 5-HT, and DRD2 positive cells was done on 20ϫ Zeiss confocal microscope
Statistical analysis
Data are presented as mean Ϯ SEM. n represents number of animals. Statistical tests are specified in figure legends (Instat software, Graph Pad Software). Differences were considered statistically significant when p Ͻ 0.05.
Results
Gpc4 gtϪ1 hypomorphic ES cell cultures showed increased morphological and immunohistochemical signs of neuronal differentiation in a well-defined 12 d single-step neuronal differentiation protocol as previously reported (Fico et al., 2008) . We further characterized the properties of Gpc4 loss-of-function cells under these culture conditions. TH, the rate-limiting enzyme for the synthesis of DA, was strongly induced (Fig. 1A) . qRT-PCR showed that as early as at day 6 of in vitro differentiation, when TH transcripts were not detectable in wild-type (wt) cultures, mutant cells (Gpc4 gtϪ1 ) already expressed TH mRNA. Over the entire analyzed time window, TH expression remained approximately fourfold over controls (Fig. 1A) .
The increased expression of TH in mutant cells could arise either from globally accelerated differentiation or from specifically enhanced DA neuron fate commitment. Quantitative analysis at 12 d in vitro (DIV) showed that in Gpc4 mutant cultures the proportion of TH ϩ presumptive DA neurons among the NeuN-expressing neuronal population was doubled compared with wt cells (wt: 9.6 Ϯ 0.6%; Gpc4 gtϪ1 : 19.6 Ϯ 1%; Fig. 1 B, C) . In contrast, the proportion of GABA ϩ cells among the NeuN ϩ neurons was unchanged (wt: 46.9 Ϯ 3%; Gpc4 gtϪ1 : 42.9 Ϯ 3.%; Fig.  1 B, C) . We also stained for parvalbumin and Islet-1 but found too few positive cells in both conditions to allow for meaningful quantification. Together, these results indicate that Gpc4 loss-offunction promotes the specification toward the DA lineage rather than promoting differentiation globally.
We next analyzed the expression dynamics of midbrain DA neuron markers in Gpc4 gtϪ1 cultures. Nurr1 displayed increased mRNA levels in Gpc4 gtϪ1 cells until 10 DIV and became undetectable at 12 DIV (Fig. 1D) , thus showing similar dynamics as in the control situation, but at higher absolute levels. Interestingly, DDC, the last enzyme in the DA biosynthesis pathway, was strongly expressed in Gpc4 gtϪ1 -derived cultures, whereas wt cells never expressed detectable mRNA levels (Fig. 1E) . Finally, the DAT was strongly induced from 10 DIV in mutant cells but not detected in wt cultures (Fig. 1F ) . Thus, decreased expression of Gpc4 in differentiating ES cells leads to increased neuronal differentiation (Fico et al., 2012 ) and a strong shift toward the mature DA neurotransmitter phenotype, even in the absence of factors, such as SHH and FGF8, that are normally added to trigger DA differentiation (Ye et al., 1998).
As Gpc4 gtϪ1 ES cells (1) generate mature dopaminergic neurons in vitro and (2) reduce tumor formation after flank trans- cell transplants in a rodent model of PD. Hemi-parkinsonian rats were generated by unilateral injection of 6-OHDA in the substantia nigra pars compacta. Five weeks later, we transplanted GFPlabeled wt versus Gpc4 gtϪ1 ES cells at low doses in the ipsilateral striatum using a embryonic body based protocol (Björklund et al., 2002) . To challenge Gpc4 gtϪ1 cells, we intentionally chose this minimal protocol because it results in teratoma formation and induces only weak behavioral improvements. At the time of brain transplantation, control and mutant cells still expressed pluripotent cell markers, such as nanog, but no neural differentiation markers, such as nestin (data not shown). Four of seven rats grafted with wt ES cells died within 6 weeks after transplantation, the scheduled endpoint of this experiment. Lethality peaked between 30 and 39 d post grafting (dpg; Fig. 2B ). In contrast, only one Gpc4 gtϪ1 -grafted animal died before the end of the experiment (day 31; Fig. 2B ).
We measured the motor improvements in grafted rats using the cylinder test and amphetamine induced rotation behavior (Björklund and Isacson, 2002) . Tests were performed on three groups: nongrafted, wt-grafted, and Gpc4 gtϪ1 -grafted rats (Fig.  2C) . The cylinder test was performed before lesion, after the lesion, and at two different time points after grafting in wt-and Gpc4 gtϪ1 -grafted rats. In the cylinder test, nongrafted hemiparkinsonian rats lost the ability to use their contralateral forepaw, inducing a dramatic decrease in double contacts on the cylinder walls (prelesioned: 78 Ϯ 2% double contacts; postlesioned/nongrafted: 13 Ϯ 3%). At 18 dpg, lesioned animals transplanted with wt cells were indistinguishable from nongrafted controls. However, at 6 weeks after grafting, use of the left paw improved in this group (nongrafted: 11 Ϯ 3%; wt-grafted: 34 Ϯ 1%). Importantly, rats grafted with Gpc4 gtϪ1 cells showed significant improvement already at 18 dpg (37 Ϯ 4%) and the effect further increased, reaching 58 Ϯ 3% of double contacts 6 weeks after transplantation (Fig. 2C) .
Animals of two independent transplantation experiments were scored for amphetamine-induced rotations at the endpoint of the experiment (Fig. 2D) . Analysis of the lesioned/nongrafted and of the lesioned/wt-grafted animals showed no significant change in net ipsilateral rotations, although there was a tendency toward improvement (sham: 12.4 Ϯ 0.8 rotations/min, wt-grafted: 4.8 Ϯ 1.4 rotations/min; Fig. 2D ). Importantly, Gpc4 gtϪ1 -grafted animals displayed a highly significant reduction in ipsilateral rotations compared with lesioned/nongrafted (Gpc4 gtϪ1 -grafted: 1.3 Ϯ 0.9 rotations/ min; Fig. 2D ). In conclusion, transplantation of Gpc4 gtϪ1 ES cells in a PD context was associated with strongly decreased lethality and was beneficial for motor functions.
We investigated size and cellular composition of the transplanted tissue. Generally, graft area was smaller in animals that received Gpc4 gtϪ1 ES-derived cells, although there was considerable heterogeneity (Fig. 3A) . In wt cell-grafted animals, graft area was positively correlated with premature death before sacrifice (Fig.  3A) . In contrast, only one of the Gpc4 gtϪ1 ES cell-grafted animals died within 6 weeks of transplantation (Fig. 2B) . Hematoxylin/ eosin staining demonstrated that all wt grafts showed the typical morphological array and dense structures indicative of teratomas (Lensch et al., 2007) , whereas the Gpc4 gtϪ1 grafts showed rather homogeneous morphology and displayed no obvious signs of teratoma-like structures (Fig. 3B) . Moreover, expression of nestin, a marker of immature neural cell types (Tohyama et al., 1992) , was observed in all grafts, but staining was considerably stronger in wt cells (Fig. 3C) . Thus, transplantation of Gpc4 hypomorphic cells strongly limited the occurrence of teratoma-like structures, which were likely the reason for augmented premature death in controls.
We then focused on the TH ϩ cells in the grafts. Importantly, Gpc4 gtϪ1 grafts displayed a sevenfold increase in TH ϩ cells compared with wt (wt grafts: 16.5 Ϯ 5.1 cells/mm 2 ; mutant grafts: 117.2 Ϯ 27.6 cells/mm 2 ; Fig. 4 A, B) . We immunohistochemically characterized the phenotypes of TH ϩ neurons in grafts. FoxA2 and Pitx3, involved in ventral midbrain dopaminergic neuron production (Nunes et al., 2003) , were both expressed in most TH ϩ neurons in grafts of wt and Gpc4 gtϪ1 origins (Fig. 4C,D) . In contrast, calbindin, a protein enriched in ventral tegmental area (Thompson et al., 2005) , was decreased in dopaminergic neurons derived from Gpc4 gtϪ1 grafts (Fig. 4C,D) , suggesting that dopaminergic neurons in Gpc4 gtϪ1 grafts were preferentially of the substantia nigra subtype. Importantly, DAT was exclusively expressed in TH ϩ neurons in Gpc4 gtϪ1 grafts (Fig. 4 B, C) , reminis- cent of the in vitro situation (Fig. 1) . In addition, most TH ϩ neurons in the Gpc4 gtϪ1 cell grafts coexpressed the DRD2 ( Fig.  4E ; DRD2/(TH ϩ DRD2): 89 Ϯ 2%), suggesting that they are capable of autoregulation. Indeed, activation of D2 autoreceptors is known to tune DA synthesis, release, and uptake as well as dopamine neuron firing. Finally, contribution of GABA and 5-HT-positive neurons to the Gpc4 gtϪ1 grafts was minor with respect to TH (GABA/(TH ϩ GABA): 8.8 Ϯ 0.4%; 5-HT/(TH ϩ 5-HT): 11.4 Ϯ 1.7%; Figure 4 F, G) .
In conclusion, decreased levels of Gpc4 increased the level of mature midbrain dopaminergic neurons after transplantation into the dopamine-depleted striatum.
Discussion
Our data suggest that interfering with Gpc4 expression or function could represent a powerful strategy to increase the efficiency and safety of cell transplantation in PD. Cultured Gpc4 hypomorphic ES cells show a strong tendency to differentiate into cells with properties of mature DA neurons. Moreover, in vivo grafted Gpc4 gtϪ1 cells show augmented differentiation into TH ϩ neurons with molecular features of midbrain DA neurons and improve recovery of motor functions in a rat model of PD. Importantly, knockdown of Gpc4 decreases the formation of teratoma-like structures and increases animal survival.
Our data indicate that Gpc4 depletion enhances DA neuron fate commitment in vitro and in vivo. Further studies will clarify whether loss of Gpc4 activity impacts also on the development of other neuronal cell types and whether distinct culture conditions could promote the capability of Gpc4 mutant cells to develop into DA neurons. Mechanistically, glypicans can interact with several signaling pathways, such as Wnt, SHH, FGFs, and BMPs, and they function either as positive or negative regulators of these signaling pathways depending on the cellular context (Galli et al., 2003; Fico et al., 2011) . We have recently shown that Gpc4 maintains mouse ES cell self-renewal by positively modulating Wnt/ ␤-catenin signaling (Fico et al., 2012) . Both the canonical (Wnt/ ␤-catenin) and noncanonical (Wnt/PCP) Wnt pathways have been implicated in midbrain DA neuron generation in vivo (Castelo-Branco and Arenas, 2006) . In particular, Wnt5a deficiency induces premature Nurr1 expression and a transitory increase in DA neurons in the ventral midbrain (Andersson et al., 2008) . In ES cells, blocking the Wnt canonical signaling increases neural induction and dopaminergic differentiation (Cajánek et al., 2009 ). Thus, it is possible that fine-tuning of Wnt signaling by Gpc4 might be a regulatory mechanism controlling the generation of midbrain DA neurons in vitro and/or in vivo. Independent of the mechanisms by which the loss of Gpc4 increases midbrain-like DA neurons, we show that reduction of Gpc4 signaling permits enhancement of DA neuron differentiation from ES cells without adding any exogenous factor, both in vitro and in vivo in a 6-OHDA rat model of PD. Moreover, at the functional level, Gpc4 hypomorphic cell-grafted rats showed strong relief of the lesion-induced motor dysfunction not only in the amphetamine-induced rotation test but also in the cylinder test, a nondrug induced test for akinesia-like deficits that is considered very stringent.
Finally, we find reduced cell overgrowth by Gpc4 hypomorphic grafts. Even the one animal in this group showing a large graft area (Fig. 3A) showed no signs of teratogenesis and survived until the end of the experiment. This is in agreement with previous work showing that Gpc4 hypomorphic ES cells do not generate teratomas after injection in the flank of nude mice (Fico et al., 2012) . Thus, control of Gpc4 may represent a means to reduce ES cell tumorigenic features while at the same time increasing neuronal features. Because Gpc4 is a cell surface protein, it appears as an attractive target to design drugs that improve security and functional improvement in PD cell therapeutic approaches.
